On July 8, 2025, Ascendis Pharma A/S granted 25,020 warrants to employees, each allowing the purchase of one share at $168.17, with 25% vesting after one year, and the rest vesting monthly thereafter. This is a significant event as it reflects on the company's incentive structure.